Researchers tout PET/CT use in lung cancer treatment

04/21/2013 | Age (Melbourne, Australia), The

Researchers at the Peter MacCallum Cancer Centre in Australia said the use of PET/CT imaging in evaluating patients with advanced lung cancer helped pave the way for significant survival gains. Data gathered from PET/CT scans allowed for tailored treatment that led to a 32% four-year survival rate, up from 10% to 20%. The finding indicates that PET/CT has potential for routine clinical use and that it could also be explored for other cancers, including head and neck cancers, melanoma and some bowel cancers, a researcher said.

View Full Article in:

Age (Melbourne, Australia), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC